Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stevan Shaw

Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study

Annals of the Rheumatic Diseases

English

Collagen II Antibody-Induced Arthritis in Tg1278TNFko Mice: Optimization of a Novel Model to Assess Treatments Targeting Human TNFα in Rheumatoid Arthritis

Journal of Translational Medicine

English

Related publications

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

English

Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”

Arthritis Research & Therapy

2019

English

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

English

Efficacy and Safety of Adalimumab in Japanese Patients With Psoriatic Arthritis and Inadequate Response to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): A Prospective, Observational Study

English

AB0490 Evaluation of Inhibitory Factor of Radiographic Progression by Iguratimod Add-On Therapy in Rheumatoid Arthritis Patients With Inadequate Responses to Disease-Modifying Anti-Rheumatic Drugs

2018

English

PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective

English

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Arthritis Research and Therapy

English

Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials

Experimental and Therapeutic Medicine

English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stevan Shaw

Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study

Collagen II Antibody-Induced Arthritis in Tg1278TNFko Mice: Optimization of a Novel Model to Assess Treatments Targeting Human TNFα in Rheumatoid Arthritis

Related publications

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Efficacy and Safety of Adalimumab in Japanese Patients With Psoriatic Arthritis and Inadequate Response to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): A Prospective, Observational Study

AB0490 Evaluation of Inhibitory Factor of Radiographic Progression by Iguratimod Add-On Therapy in Rheumatoid Arthritis Patients With Inadequate Responses to Disease-Modifying Anti-Rheumatic Drugs

PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study